Advertisement

Topics

Eylea sales up in first quarter

10:30 EDT 21 Jun 2017 | Healio

Eylea net product sales totaled $854 million in the United States for the first quarter, up 9% over the same quarter last year, according to a Regeneron press release.In the first quarter of 2016, Eylea (aflibercept) injection sales totaled $781 million.

Original Article: Eylea sales up in first quarter

NEXT ARTICLE

More From BioPortfolio on "Eylea sales up in first quarter"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...